Melatonin modulation of lymphocyte proliferation and Th1/Th2 cytokine expression

E Kühlwein1, M Irwin

  • 1Veterans Affairs San Diego Healthcare System, Department of Psychiatry, University of California, San Diego, La Jolla, CA 92161, USA.

Insights

Melatonin, a hormone, was found to boost human peripheral blood mononuclear cell (PBMC) proliferation in vitro. This effect may be linked to reduced levels of the inhibitory cytokine Interleukin-10 (IL-10).

Area of Science:

  • Immunology
  • Endocrinology
  • Neuroscience

Background:

  • Melatonin is a hormone with potential neuroimmunomodulatory functions.
  • Its specific effects on human immune cell function require further elucidation.

Purpose of the Study:

  • To investigate the in vitro effects of melatonin on human peripheral blood mononuclear cell (PBMC) proliferation.
  • To examine the impact of melatonin on T helper type 1 (Th1) and T helper type 2 (Th2) cytokine expression.

Main Methods:

  • Human PBMCs were cultured with varying melatonin concentrations (10(-12) - 10(-6) M).
  • PBMC proliferation was assessed.
  • Cytokine expression (IFN-gamma, IL-10) and activation antigen (CD69) were measured using flow cytometry and culture supernatant analysis.

Main Results:

  • Physiologic doses of melatonin significantly increased PBMC proliferation (p<0.05).
  • Melatonin significantly decreased IL-10 production in culture supernatants (p<0.05).
  • No significant effects were observed on stimulated IFN-gamma production or intracellular CD69, IFN-gamma, or IL-10 levels.

Conclusions:

  • Physiologic doses of melatonin enhance lymphocyte proliferation in vitro.
  • This proliferative effect may be mediated by a reduction in the inhibitory cytokine IL-10.
  • Melatonin's role in neuroimmunomodulation warrants further investigation.